Insider · CIK 0001306506
Michael A Carusi
director
Files at SI (SHOULDER INNOVATIONS, INC.). First filing Aug 5, 2025, latest Aug 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$4.0M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SI: SHOULDER INNOVATIONS, INC.
SIOct 9, 2026 · close 18.13
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | SHOULDER INNOVATIONS, INC. | $4.0M 266,666 shares | +16% | 0% from low-5% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | CConversion Common Stockindirect: See Footnotes | +1,618,470 | - | - | 1,618,470 | Aug 5, 2025 |
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | POpen-market purchase Common Stockindirect: See Footnotes | +266,666 | $15.00 | $4.0M | 1,885,136 | Aug 5, 2025 |
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | AGrant or award Common Stock | +7,666 | $0.00 | $0 | 7,666 | Aug 5, 2025 |
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | CConversion Series C Convertible Preferred Stockderivativeindirect: See Footnotes | -20,930,233 | - | - | 0 | Aug 5, 2025 |
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | CConversion Series D Convertible Preferred Stockderivativeindirect: See Footnotes | -9,950,208 | - | - | 0 | Aug 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.